NO by endothelial nitric oxide synthase (NOS3) is implicated in vascular smooth muscle relaxation and mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels, which may explain the many complications occurring in COVID-19 patients [51]. This evidence concerns the gene VEGFA and COVID-19.